
- This event has passed.
NCCN 2024 Annual Congress: Hematologic Malignancies

The NCCN 2024 Annual Congress: Hematologic Malignancies, chaired by Dr. Andrew D. Zelenetz from Memorial Sloan Kettering Cancer Center, will feature presentations and discussions on treatment options and supportive care for various hematologic malignancies. This program is approved for AMA PRA Category 1 Creditâ„¢ and ABIM, ABPath, and ABMS MOC for physicians and is certified for credit for PAs, nurses, pharmacists, and other oncology professionals. Topics covered will include: Leukemias, Lymphomas, Multiple Myeloma, Myelodysplastic Syndromes (MDS), Myelofibrosis, Novel Therapies (e.g., CAR T-Cell Therapies, Bispecific Antibodies), and Supportive Care in Hematologic Malignancies.
